<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>UBA7-pathway</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            line-height: 1.6;
            color: #333;
            max-width: 900px;
            margin: 0 auto;
            padding: 20px;
            background: #f5f5f5;
        }
        .content {
            background: white;
            padding: 30px;
            border-radius: 8px;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        h1, h2, h3, h4, h5, h6 {
            color: #2c3e50;
            margin-top: 24px;
            margin-bottom: 16px;
        }
        h1 { border-bottom: 2px solid #3498db; padding-bottom: 10px; }
        h2 { border-bottom: 1px solid #ecf0f1; padding-bottom: 8px; }
        code {
            background: #f4f4f4;
            padding: 2px 6px;
            border-radius: 3px;
            font-family: 'Courier New', monospace;
        }
        pre {
            background: #2c3e50;
            color: #ecf0f1;
            padding: 15px;
            border-radius: 5px;
            overflow-x: auto;
        }
        pre code {
            background: none;
            padding: 0;
            color: inherit;
        }
        blockquote {
            border-left: 4px solid #3498db;
            margin-left: 0;
            padding-left: 20px;
            color: #555;
        }
        table {
            border-collapse: collapse;
            width: 100%;
            margin: 20px 0;
        }
        th, td {
            border: 1px solid #ddd;
            padding: 12px;
            text-align: left;
        }
        th {
            background: #3498db;
            color: white;
        }
        tr:nth-child(even) {
            background: #f9f9f9;
        }
        .mermaid {
            text-align: center;
            margin: 30px 0;
            background: white;
            padding: 20px;
            border-radius: 8px;
            border: 1px solid #e0e0e0;
        }
        .mermaid svg {
            max-width: 100%;
            height: auto;
        }
        a {
            color: #3498db;
            text-decoration: none;
        }
        a:hover {
            text-decoration: underline;
        }
        .toc {
            background: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 5px;
            padding: 15px;
            margin-bottom: 20px;
        }
        .toc ul {
            list-style-type: none;
            padding-left: 20px;
        }
        .toc > ul {
            padding-left: 0;
        }
    </style>
    
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        // Initialize mermaid with custom settings
        mermaid.initialize({ 
            startOnLoad: true,
            theme: 'default',
            themeVariables: {
                primaryColor: '#3498db',
                primaryTextColor: '#fff',
                primaryBorderColor: '#2c3e50',
                lineColor: '#333',
                secondaryColor: '#ecf0f1',
                tertiaryColor: '#f39c12'
            },
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="content">
        <h1 id="pathway-summary-for-uba7">Pathway Summary for UBA7</h1>
<h2 id="overview">Overview</h2>
<p>UBA7 (Ubiquitin-like Modifier Activating Enzyme 7) is the E1 activating enzyme for ISG15, a ubiquitin-like protein induced by interferon signaling. UBA7 initiates ISGylation, a post-translational modification system that conjugates ISG15 to target proteins, playing critical roles in antiviral immunity and immune regulation.</p>
<h2 id="core-pathways">Core Pathways</h2>
<h3 id="isgylation-cascade">ISGylation Cascade</h3>
<p>UBA7 initiates ISG15 conjugation through:<br />
- ATP-dependent ISG15 activation<br />
- Thioester bond formation with ISG15<br />
- Transfer to UBE2L6 (E2 enzyme)<br />
- Ultimate conjugation by HERC5/TRIM25 (E3 ligases)</p>
<h3 id="interferon-response-pathway">Interferon Response Pathway</h3>
<p>UBA7 is a key effector of type I interferon signaling:<br />
- Induced by IFN-α/β through JAK-STAT<br />
- ISGylates viral and host proteins<br />
- Restricts viral replication<br />
- Modulates immune responses</p>
<h2 id="pathway-diagram">Pathway Diagram</h2>
<div class="mermaid">
graph TD
    A[Type I IFN] --> B[JAK-STAT]
    B --> C[ISG15 Expression]
    B --> D[UBA7: E1 Enzyme]

    C --> D
    E[ATP] --> D
    D -->|activation| F[ISG15~UBA7]
    F --> G[UBE2L6: E2]
    G --> H[HERC5/TRIM25: E3]
    H --> I[Target ISGylation]

    I --> J[Antiviral Response]
    I --> K[Immune Modulation]

    L[USP18: DeISGylase] --|removes ISG15| I

    M[Viral Proteins] --> I
    N[Host Proteins] --> I

    style D fill:#f9f,stroke:#333,stroke-width:2px
    style I fill:#ffd,stroke:#333,stroke-width:1px
</div>

<h2 id="upstream-regulation">Upstream Regulation</h2>
<ul>
<li><strong>Type I interferons</strong>: Primary inducers via ISGF3</li>
<li><strong>Viral infection</strong>: Triggers IFN production</li>
<li><strong>TLR signaling</strong>: Pattern recognition response</li>
<li><strong>IRF3/7</strong>: Transcription factors</li>
</ul>
<h2 id="downstream-effects">Downstream Effects</h2>
<ul>
<li><strong>Viral restriction</strong>: ISGylation of viral proteins</li>
<li><strong>Translation regulation</strong>: Modified host factors</li>
<li><strong>Signaling modulation</strong>: ISGylated regulators</li>
<li><strong>Cytokine production</strong>: Immune response tuning</li>
</ul>
<h2 id="clinical-significance">Clinical Significance</h2>
<ul>
<li><strong>ISG15 deficiency</strong>: Susceptibility to mycobacterial disease</li>
<li><strong>Autoinflammation</strong>: Dysregulated ISGylation</li>
<li><strong>Cancer</strong>: Altered expression in malignancies</li>
<li><strong>Therapeutic target</strong>: Modulating antiviral immunity</li>
</ul>
<h2 id="molecular-mechanism">Molecular Mechanism</h2>
<ul>
<li><strong>ATP binding</strong>: Required for ISG15 activation</li>
<li><strong>Adenylation</strong>: ISG15 C-terminus activation</li>
<li><strong>Thioester formation</strong>: Cys-ISG15 intermediate</li>
<li><strong>Trans-thiolation</strong>: Transfer to E2 enzyme</li>
</ul>
<h2 id="integration-with-immunity">Integration with Immunity</h2>
<ul>
<li><strong>Antiviral defense</strong>: Core effector mechanism</li>
<li><strong>Bacterial immunity</strong>: Antimycobacterial responses</li>
<li><strong>Inflammatory regulation</strong>: Balances immune activation</li>
<li><strong>Cross-talk</strong>: Interacts with ubiquitination system</li>
</ul>
    </div>
    <footer style="text-align: center; padding: 20px; color: #666;">
        <small>Generated from UBA7-pathway.md</small>
    </footer>
</body>
</html>